Glenview Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Glenview Trust’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$271K	Hold	1,711	–	–	﹤0.01%	458
2026 Q1	$219K	Hold	1,711	–	–	﹤0.01%	474
2025 Q4	$209K	Buy	+1,711	New	+$196K	﹤0.01%	480
2023 Q1	–	Sell	-2,673	Closed	-$222K	–	456
2022 Q4	$222K	Hold	2,673	–	–	0.01%	413
2022 Q3	$212K	Buy	+2,673	New	+$225K	0.01%	390
2022 Q2	–	Sell	-2,673	Closed	-$240K	–	427
2022 Q1	$240K	Sell	2,673 -500	-16%	-$46.2K	0.01%	390
2021 Q4	$355K	Sell	3,173 -75	-2%	-$9.05K	0.01%	337
2021 Q3	$409K	Hold	3,248	–	–	0.02%	291
2021 Q2	$440K	Hold	3,248	–	–	0.02%	286
2021 Q1	$440K	Hold	3,248	–	–	0.02%	280
2020 Q4	$457K	Hold	3,248	–	–	0.02%	244
2020 Q3	$362K	Hold	3,248	–	–	0.02%	260
2020 Q2	$364K	Hold	3,248	–	–	0.02%	255
2020 Q1	$251K	Hold	3,248	–	–	0.02%	280
2019 Q4	$309K	Sell	3,248 -150	-4%	-$13K	0.02%	290
2019 Q3	$259K	Hold	3,398	–	–	0.02%	307
2019 Q2	$299K	Hold	3,398	–	–	0.02%	288
2019 Q1	$307K	Hold	3,398	–	–	0.02%	281
2018 Q4	$244K	Hold	3,398	–	–	0.02%	292
2018 Q3	$326K	Sell	3,398 -500	-13%	-$48.5K	0.02%	275
2018 Q2	$371K	Hold	3,898	–	–	0.03%	239
2018 Q1	$342K	Hold	3,898	–	–	0.02%	270
2017 Q4	$331K	Hold	3,898	–	–	0.02%	278
2017 Q3	$337K	Buy	3,898 +500	+15%	+$40.1K	0.02%	265
2017 Q2	$262K	Hold	3,398	–	–	0.02%	288
2017 Q1	$236K	Hold	3,398	–	–	0.02%	292
2016 Q4	$201K	Buy	+3,398	New	+$210K	0.02%	304

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Glenview Trust's XBI Position: Q2 2026 in Review

Glenview Trust held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 1,711 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #458.

Glenview Trust first reported a position in XBI in Q4 2016 and has held it in 27 quarters since. The position peaked at $457K in Q4 2020. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Glenview Trust held 1,711 shares of State Street SPDR S&P Biotech ETF worth $271K as of Q2 2026.
Glenview Trust left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Glenview Trust's portfolio in Q2 2026, its #458 holding.
Glenview Trust first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and has held it in 27 quarters since.
Glenview Trust's State Street SPDR S&P Biotech ETF position peaked at $457K in Q4 2020.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Glenview Trust's 13F filing for Q2 2026, filed 11 Aug 2026.